| Andrus Vision Center | |
|
749 S River Rd, St George, UT 84790 | |
| (435) 628-4464 | |
| (435) 628-5015 |
| Full Name | Andrus Vision Center |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 749 S River Rd, St George, Utah |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639404304 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 7370571 (Utah) | Primary |
| Provider Name | Adam J Lofgran |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1528297900 PECOS PAC ID: 5193862712 Enrollment ID: I20091029000685 |
News Archive
Despite advances in managing and curing some forms of breast cancer, women whose disease becomes metastatic have fewer effective options. A new phase 3 study in some of the most difficult-to-treat patients, women with endocrine-resistant disease, showed that the newly approved drug, palbociclib, more than doubled the time to cancer recurrence for women with hormone-receptor (HR+) positive metastatic breast cancer.
Abnormally high blood sugar may worsen outcomes and mortality rates for COVID-19 patients, including those without diabetes, according to major research published in the peer-reviewed open access journal Annals of Medicine.
The U.S. Food and Drug Administration approved VENTANA anti-ALK(D5F3)CDx performed more accurately than another commonly used immunohistochemistry (IHC) assay, based on the use of the 5A4 clone, for the selection of patients eligible to receive ALK tyrosine kinase inhibitor (TKI) treatment.
Researchers at the University of Michigan have evidence that a single gene controls both halves of nerve cells, and their research demonstrates the need to consider that design in the development of new treatments for regeneration of nerve cells.
› Verified 4 days ago
| Provider Name | Trevor G Hammons |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1558657585 PECOS PAC ID: 1951551613 Enrollment ID: I20121016000180 |
News Archive
Despite advances in managing and curing some forms of breast cancer, women whose disease becomes metastatic have fewer effective options. A new phase 3 study in some of the most difficult-to-treat patients, women with endocrine-resistant disease, showed that the newly approved drug, palbociclib, more than doubled the time to cancer recurrence for women with hormone-receptor (HR+) positive metastatic breast cancer.
Abnormally high blood sugar may worsen outcomes and mortality rates for COVID-19 patients, including those without diabetes, according to major research published in the peer-reviewed open access journal Annals of Medicine.
The U.S. Food and Drug Administration approved VENTANA anti-ALK(D5F3)CDx performed more accurately than another commonly used immunohistochemistry (IHC) assay, based on the use of the 5A4 clone, for the selection of patients eligible to receive ALK tyrosine kinase inhibitor (TKI) treatment.
Researchers at the University of Michigan have evidence that a single gene controls both halves of nerve cells, and their research demonstrates the need to consider that design in the development of new treatments for regeneration of nerve cells.
› Verified 4 days ago
| Provider Name | Christopher Rae Wood |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1548768997 PECOS PAC ID: 0840553731 Enrollment ID: I20180405001644 |
News Archive
Despite advances in managing and curing some forms of breast cancer, women whose disease becomes metastatic have fewer effective options. A new phase 3 study in some of the most difficult-to-treat patients, women with endocrine-resistant disease, showed that the newly approved drug, palbociclib, more than doubled the time to cancer recurrence for women with hormone-receptor (HR+) positive metastatic breast cancer.
Abnormally high blood sugar may worsen outcomes and mortality rates for COVID-19 patients, including those without diabetes, according to major research published in the peer-reviewed open access journal Annals of Medicine.
The U.S. Food and Drug Administration approved VENTANA anti-ALK(D5F3)CDx performed more accurately than another commonly used immunohistochemistry (IHC) assay, based on the use of the 5A4 clone, for the selection of patients eligible to receive ALK tyrosine kinase inhibitor (TKI) treatment.
Researchers at the University of Michigan have evidence that a single gene controls both halves of nerve cells, and their research demonstrates the need to consider that design in the development of new treatments for regeneration of nerve cells.
› Verified 4 days ago
| Provider Name | David J Pace |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1558923854 PECOS PAC ID: 6901222017 Enrollment ID: I20200820000687 |
News Archive
Despite advances in managing and curing some forms of breast cancer, women whose disease becomes metastatic have fewer effective options. A new phase 3 study in some of the most difficult-to-treat patients, women with endocrine-resistant disease, showed that the newly approved drug, palbociclib, more than doubled the time to cancer recurrence for women with hormone-receptor (HR+) positive metastatic breast cancer.
Abnormally high blood sugar may worsen outcomes and mortality rates for COVID-19 patients, including those without diabetes, according to major research published in the peer-reviewed open access journal Annals of Medicine.
The U.S. Food and Drug Administration approved VENTANA anti-ALK(D5F3)CDx performed more accurately than another commonly used immunohistochemistry (IHC) assay, based on the use of the 5A4 clone, for the selection of patients eligible to receive ALK tyrosine kinase inhibitor (TKI) treatment.
Researchers at the University of Michigan have evidence that a single gene controls both halves of nerve cells, and their research demonstrates the need to consider that design in the development of new treatments for regeneration of nerve cells.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrus Vision Center 749 S River Rd, St George, UT 84790-5509 Ph: (435) 628-4464 | Andrus Vision Center 749 S River Rd, St George, UT 84790 Ph: (435) 628-4464 |
News Archive
Despite advances in managing and curing some forms of breast cancer, women whose disease becomes metastatic have fewer effective options. A new phase 3 study in some of the most difficult-to-treat patients, women with endocrine-resistant disease, showed that the newly approved drug, palbociclib, more than doubled the time to cancer recurrence for women with hormone-receptor (HR+) positive metastatic breast cancer.
Abnormally high blood sugar may worsen outcomes and mortality rates for COVID-19 patients, including those without diabetes, according to major research published in the peer-reviewed open access journal Annals of Medicine.
The U.S. Food and Drug Administration approved VENTANA anti-ALK(D5F3)CDx performed more accurately than another commonly used immunohistochemistry (IHC) assay, based on the use of the 5A4 clone, for the selection of patients eligible to receive ALK tyrosine kinase inhibitor (TKI) treatment.
Researchers at the University of Michigan have evidence that a single gene controls both halves of nerve cells, and their research demonstrates the need to consider that design in the development of new treatments for regeneration of nerve cells.
› Verified 4 days ago
Dr. Brent Larry Croft, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 301 E Tabernacle St, Ste. 101, St George, UT 84770 Phone: 435-673-3558 Fax: 435-673-9181 | |
Luca Albernaz Reggiani, OD Optometrist Medicare: Medicare Enrolled Practice Location: 161 W 200 N Ste 200, St George, UT 84770 Phone: 435-986-2020 | |
Ames Eyecare, Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 2610 Pioneer Rd, St George, UT 84790 Phone: 435-674-9770 Fax: 435-674-9771 | |
Dr. Kent S Albrecht, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 10 Diagonal St, Suite 101, St George, UT 84770 Phone: 435-673-3201 Fax: 435-673-3552 | |
The Children's Vision Center Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1490 E Foremaster Dr Ste 120, St George, UT 84790 Phone: 435-429-1686 | |
Harlin Optometry, Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2610 Pioneer Rd, St George, UT 84790 Phone: 435-674-9770 Fax: 435-674-9771 | |
Derek Busenbark Ames, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 2610 Pioneer Rd, St George, UT 84790 Phone: 435-674-9770 Fax: 435-674-9771 |